News Releases
- Chugai’s PiaSky Launched as Taiwan’s First Approved Subcutaneous Treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Roche’s Announcement Regarding giredestrant (Presentation of Phase III evERA Study Results)
- Chugai Files for Additional Indication of Avastin for the Treatment of Neurofibromatosis Type 2
Science and Technology
Science and Technology
Careers at Chugai
Careers at Chugai
Videos
CPR celebrates 10th Anniversary